This special focus issue of Expert Review of Molecular Diagnostics on in vitro companion
diagnostics aims to provide the reader with up-to-date knowledge on this fast-evolving area …

As drug discovery and translational scientists think about using stratification with biomarkers
to improve the chances of getting medicines to patients, several areas of expertise need to …

Patients expect medical treatments that work and are safe and “right” for them as individuals.
Biomarkers can help bio-pharmaceutical and diagnostics companies to focus more on …

Advances in decoding integrated biological processes; the surge in enabling technologies
including the highthroughput platforms of genomics, proteomics, and metabolomics; and the …

Changes in technology can often affect society and models of industry. The broad
expectations for 'genomics' that were highly publicized during the previous decade have not …

Companion diagnostics are in vitro clinical laboratory assays designed to predict the efficacy
of a targeted cancer therapy through assessment of 1 or more biomarkers whose status in a …

Expected benefits from new technology include more efficient patient selection for clinical
trials, more cost-effective treatment pathways for patients and health services and a more …

The field of personalized medicine that involves the use of measuring biomarkers in clinical
samples is an area of high interest and one that has tremendous impact on drug …

Personalized medicine, sometimes referred to as precision medicine, is a paradigm shift in
healthcare. This model is based on the concept of customizing prevention and treatment …

The revolution in disease diagnosis and treatment promised on the completion of the human
genome project over a decade ago has materialized in the form of unified drug and …